(Q46149716)

19 December 2017

title

Impact of ABCB1 (MDR1) haplotypes on tacrolimus dosing in adult lung transplant patients who are CYP3A5 *3/*3 non-expressors (English)

1 reference

19 December 2017

1 reference

2

Adriana Zeevi

1 reference

19 December 2017

Jian Wang

1

1 reference

19 December 2017

Kenneth McCurry

3

1 reference

19 December 2017

Erin Schuetz

4

1 reference

19 December 2017

Hongxia Zheng

5

1 reference

19 December 2017

Aldo Iacono

6

1 reference

19 December 2017

Kevin McDade

7

1 reference

19 December 2017

Diana Zaldonis

8

1 reference

19 December 2017

Steven Webber

9

1 reference

19 December 2017

Richard M Watanabe

10

1 reference

19 December 2017

Gilbert J Burckart

11

1 reference

19 December 2017

publication date

8 September 2005

1 reference

19 December 2017

published in

Transplant Immunology

1 reference

19 December 2017

volume

15

1 reference

19 December 2017

issue

3

1 reference

19 December 2017

page(s)

235-240

1 reference

19 December 2017

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.08.001

P-glycoprotein (P-gp) is upregulated in peripheral T-cell subsets from solid organ transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.08.001

Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.08.001

Genetic polymorphisms of the human MDR1 drug transporter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.08.001

The role of MDR1 genetic polymorphisms in interindividual variability in P-glycoprotein expression and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.08.001

Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.08.001

Tacrolimus Dosing in Pediatric Heart Transplant Patients is Related to CYP3A5 and MDR1 Gene Polymorphisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.08.001

The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.08.001

Influence of CYP3A5 and MDR1 (ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.08.001

CYP3A5*1-carrying graft liver reduces the concentration/oral dose ratio of tacrolimus in recipients of living-donor liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.08.001

C3435T polymorphism in the MDR1 gene affects the enterocyte expression level of CYP3A4 rather than Pgp in recipients of living-donor liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.08.001

Impact of CYP3A5 and MDR1(ABCB1) C3435T polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.08.001

Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.08.001

Tacrolimus dosing in adult lung transplant patients is related to cytochrome P4503A5 gene polymorphism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.08.001

Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and P-glycoprotein correlate with dose requirement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.08.001

MDR1 haplotypes derived from exons 21 and 26 do not affect the steady-state pharmacokinetics of tacrolimus in renal transplant patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.08.001

Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.08.001

Identification of functionally variant MDR1 alleles among European Americans and African Americans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.08.001

Pharmacogenetics in solid organ transplantation: present knowledge and future perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.08.001

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.08.001

Impact of cytochrome p450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.08.001

The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.08.001

Tacrolimus pharmacogenetics: the CYP3A5*1 allele predicts low dose-normalized tacrolimus blood concentrations in whites and South Asians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.08.001

Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.08.001

Ethnic differences in genetic polymorphisms of CYP2D6, CYP2C19, CYP3As and MDR1/ABCB1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.08.001

Racial variation in dosage requirements of tacrolimus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.08.001

Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.08.001

The pharmacokinetics and metabolic disposition of tacrolimus: a comparison across ethnic groups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2005.08.001

10.1016/J.TRIM.2005.08.001

7 January 2021

Identifiers

DOI

1 reference

19 December 2017

1 reference

19 December 2017